NUTX

NUTEX HEALTH INC.

NUTX · CIK 1479681 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$258M
20162024
Net Income$62M
20162024
Operating CF$23M
20162024
Free Cash Flow
20162024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2017↕FY 2016↕
Revenue$0.3B$0.1B$0.1B$0.0B$0.0B$0.0B$0.0B—
Cost of Revenue———$0.0B$0.0B$0.0B$0.0B—
Gross Profit$0.1B$0.0B$0.0B$0.0B$0.0B$0.0B$-0.0B—
R&D Expense———$0.0B$0.0B$0.0B——
SG&A Expense————————
Operating Income$0.1B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Net Income$0.1B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$0.0B$-0.0B
EPS (Basic)$11.83$-0.05$-0.02—————
EPS (Diluted)$11.12$-0.05$-0.02—————

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2017↕FY 2016↕
Total Assets$0.7B$0.4B$0.4B$0.1B$0.0B$0.0B$0.0B$0.0B
Current Assets$0.3B$0.1B$0.1B$0.0B$0.0B$0.0B$0.0B$0.0B
Cash & Equivalents$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Total Liabilities$0.5B$0.3B$0.3B$0.0B$0.0B$0.0B—$0.0B
Current Liabilities$0.1B$0.1B$0.1B$0.0B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.1B$0.1B$0.1B—$-0.0B$0.0B$0.0B—

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2017↕FY 2016↕
Operating Cash Flow$0.0B$0.0B$0.1B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Investing Cash Flow$-0.0B$-0.0B$-0.0B$0.0B$-0.0B$-0.0B$0.0B$-0.0B
Capital Expenditures——$0.0B—$0.0B$0.0B——
Financing Cash Flow$0.0B$-0.0B$-0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
← Companies